NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAAA E-060-2010-0-PCT-02 Hydroxybutyrate Ester And Medical Use Thereof PCT PCT PCT/US09/040766 Expired
NIAAA E-061-2010-0-PCT-01 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE PCT PCT PCT/US09/040773 Expired
NICHD E-167-2009-0-US-01 Cholesterol Therapy For Autistic Spectrum Disorder US 61/169,775 Abandoned
NCI E-174-2008-0-AU-04 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma AU National Stage 2009236219 Issued
NIA E-051-2008-0-AU-03 Compositions And Methods For Delivering Inhibitory Oligonucleotides AU National Stage 2009236270 Abandoned
NCI E-174-2008-0-EP-06 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA EP National Stage 09731523.8 Issued
NIA E-051-2008-0-PCT-02 CHEMOARP -A SIMPLE AND EFFICIENT TECHNOLOGY FOR DELIVERING SIRNA PCT PCT PCT/US2009/040607 Expired
NCI E-174-2008-0-EP-11 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA EP DIV 9731523.8 Abandoned
NIA E-051-2008-0-EP-05 COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES EP National Stage 09733166.4 Abandoned
NIDA E-250-2009-0-US-01 Monoamine Reuptake Inhibitors US 61/169,586 Abandoned
NIA E-051-2008-0-CA-04 COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES CA National Stage 2720363 Abandoned
NCI E-174-2008-0-CA-05 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma CA National Stage 2721380 Abandoned
NCI E-174-2008-0-PCT-02 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma PCT PCT PCT/US09/040685 Expired
NCI E-175-2008-0-US-02 OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS US ORD 12/423,750 8216783 Abandoned PDF
NHLBI E-138-2008-0-PCT-02 Hypertriglyceridemia From ApoA-I And ApoA-I Mimetic Peptides PCT PCT PCT/US2009/040560 Expired
NICHD E-120-2015-0-US-01 Method For On-demand Contraception US 61/169,149 Abandoned
NICHD E-098-2008-0-US-02 Biomarkers for niemann-pick C disease and related disorders US ORD 12/385,529 8497122 Issued PDF
NIAID E-142-2008-0-PCT-02 Humanized Monoclonal Antibodies Derived From Chimpanezee Fabs Efficient For Neutralization Of Japanese Virus (JEV) In Vitro And Protection Against JEV Infection In Mice PCT PCT PCT/US2009/040227 Expired
NIDDK E-173-2008-0-PCT-02 MDCK Cells With Human Siat7e Gene Inserts Exhibit Capability Of Anchorage-independent Growth PCT PCT PCT/US2009/002252 Expired
NCI E-160-2006-0-GB-07 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS GB EP 07842310.0 Issued
NCI E-160-2006-0-FR-06 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS FR EP 07842310.0 Issued
NCI E-160-2006-0-DE-05 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS DE EP 07842310.0 Issued
NHGRI E-312-2006-0-US-03 Methods for Detecting Attention Deficit Hyperactivity Disorder (ADHD) US National Stage 12/444,898 8003406 Abandoned PDF
NCI E-013-2008-0-US-01 Human Monoclonal Antibodies Against Yeresinia Pestis US 61/212,166 Abandoned
NCI E-154-1998-0-EP-08 RECOMBINANT POX VIRUS FOR IMMUNIZATION AGAINST MUCI TUMOR-ASSOCIATED ANTIGEN EP DIV 09005114.5 Abandoned
NHGRI E-099-2009-0-US-01 Device And Method For Direct Measurement Of Isotopes Of Expired Gases US ORD 12/418,795 8293187 Issued PDF
NCI E-266-2008-0-US-02 Single Chain Antibodies that Bind to Chondroitin Sulfate Proteoglycans US ORD 12/418,956 Abandoned
NIDDK E-063-2007-1-US-03 Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure US National Stage 12/419,062 Abandoned
NCI E-207-2008-0-US-02 Dual Specific Immunotoxin for Brain Tumor Therapy US ORD 12/418,975 Abandoned
NIDDK E-063-2007-1-MX-09 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE MX National Stage MX/A/2009/003750 Pending
NIDDK E-063-2007-1-JP-08 EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE JP National Stage 2009531464 Abandoned
NCI E-336-2005-0-MX-11 ANTIBODY COMPOSITIONS AND METHODS FOR TREATMENT OF NEOPLASTIC DISEASE MX National Stage 08/12754 Abandoned
NCI E-227-2006-5-US-02 Prevention Of Tissue Ischemia, Related Methods and Compositions US ORD 12/444,364 8236313 Issued PDF
NIDDK E-159-2008-0-PCT-02 Polyamine Compounds That Binds Tar RNA of HIV and Methods of Treating Viral Disorders PCT PCT PCT/US2009/002116 Expired
NCI E-338-2008-0-PCT-01 HMGN3 As A Novel Diagnostic Marker For Diabetes PCT PCT PCT/US09/039406 Expired
NINDS E-081-2008-1-US-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US 61/166,610 Expired
NINDS E-309-2009-0-US-01 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US 61/166,610 Abandoned
NIDDK E-219-2011-1-US-01 CLINICAL DECISION MODEL US 61/166,245 Abandoned
NIEHS E-009-2009-0-AU-03 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease AU National Stage 2009325088 Abandoned
NCI E-080-2008-0-PCT-02 Human And Improved Murine Monoclonal Antibodies Against CD22 PCT PCT PCT/US2009/039080 Expired
NIEHS E-009-2009-0-PCT-02 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease PCT PCT PCT/US2009/039157 Expired
NIAID E-306-2006-4-US-07 Avain Influenza Vaccine US National Stage 12/443,964 Abandoned
NIEHS E-009-2009-0-CA-04 Inhibition of Inter-Alpha-Trypsin Inhibitor for the Treatment of Airway Disease CA National Stage 2743768 Abandoned
NCI E-058-2009-0-US-01 Generation And Application Of Antibodies That Bind GaLNAc1-3Gal US 61/165,675 Abandoned
NCI E-332-2007-0-AU-04 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling AU National Stage 2009231841 Abandoned
NCI E-332-2007-0-PCT-03 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling PCT PCT PCT/US2009/038915 Expired
NCI E-332-2007-0-PCT-02 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling PCT PCT PCT/US2009/038896 Expired
NCI E-332-2007-0-EP-06 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling EP National Stage 09727676.0 Abandoned
NCI E-332-2007-0-HK-09 Compositions and Methods for Inhibition of Hepatocyte Growth Factor Receptor c-Met Signaling HK EP 11106440.0 Abandoned
NCI E-311-2006-1-IT-12 Compositions And Methods For Chitosan Enhanced Immune Response IT EP 07838692.7 Abandoned